Arlette Garnier

Novartis (Switzerland)

Papers

1

Total Citations

158

H-Index

1

About

Arlette Garnier is a pioneer in the functional genomics of non-coding RNAs, with a career-defining focus on microRNA (miRNA) biology and high-throughput expression profiling. Her most celebrated contribution, the 2007 paper "A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs," has garnered 158 citations and established a foundational methodology for the field. In this work, Garnier developed an innovative microarray platform that enabled the systematic, in-parallel examination of global miRNA expression levels, moving beyond single-gene studies to reveal comprehensive tissue-specific signatures. This breakthrough allowed researchers to identify both known and previously predicted miRNAs, providing critical insights into RNA-based regulation and its implications in human diseases. By creating a tool that could simultaneously profile hundreds of miRNAs, Garnier empowered the scientific community to explore how these small molecules orchestrate complex biological processes and contribute to pathology. Her work remains a cornerstone for studies in miRNA diagnostics and therapeutics, cementing her legacy as a key architect in the transition from gene discovery to systems-level understanding of regulatory RNA networks.

Research Focus

Key Achievements

1
H-Index
1
Papers
158
Total Citations
158
Avg Citations/Paper
🏆 Most Cited Paper
A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs
158 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Novartis (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago